This inventor holds 1 USPTO granted patent. Top assignee: Novo Nordisk A/s. Active years: 1999.
Company Filing History:
Years Active: 1999
Title: Ruby Iium Nielsen: Innovator in Enzyme Technology
Introduction
Ruby Iium Nielsen is a notable inventor based in Farum, Denmark. She has made significant contributions to the field of enzyme technology, particularly through her innovative work on endoglucanases. Her research has implications for various industries, including biotechnology and pharmaceuticals.
Latest Patents
Ruby holds 1 patent related to enzyme preparations that exhibit cellulytic activity. The patent describes an enzyme comprising a specific amino acid sequence of 14 residues, which plays a crucial role in the breakdown of cellulose. This invention has the potential to enhance processes in various applications, including biofuel production and waste management.
Career Highlights
Ruby Iium Nielsen is associated with Novo Nordisk A/S, a leading global healthcare company. Her work at Novo Nordisk has allowed her to focus on developing innovative solutions that address critical challenges in enzyme applications. Her expertise in this area has positioned her as a key figure in enzyme research.
Collaborations
Throughout her career, Ruby has collaborated with esteemed colleagues, including Lene Nonboe Andersen and Markus Sakari Kauppinen. These collaborations have fostered a productive research environment, leading to advancements in enzyme technology.
Conclusion
Ruby Iium Nielsen's contributions to enzyme technology exemplify her dedication to innovation and research. Her work continues to influence the field and pave the way for future advancements in biotechnology.